DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/5f7b75/2016_uk) has announced the addition of the "2016 UK Immunoprotein Diagnostic Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers" report to their offering.
This new report provides analysis of the UK immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
During the next five years, the immunoprotein testing market will undergo significant transformation. The changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
2016 UK Immunoprotein Diagnostic Testing Market is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; provides test volume and sales forecasts by market segment and individual test; compares features of leading analyzers; and profiles key competitors.
- Abbott Laboratories
- Agilent Technologies
- Bayer Healthcare
- Beckman Coulter/Danaher
- Biomedical Diagnostics
- Instrumentation Laboratory
- Kyowa Medex
- Ortho-Clinical Diagnostics
- Quest Diagnostics
- Thermo Fisher
For more information visit http://www.researchandmarkets.com/research/5f7b75/2016_uk